电生理及血管介入

Search documents
最新宣布,5只A股被调入名单!股价纷纷冲高
Zheng Quan Ri Bao Wang· 2025-05-14 05:46
Group 1 - MSCI announced the inclusion of 30 new stocks and the removal of 61 stocks from its global equity index, with 5 A-shares from China being added [1] - The newly added A-shares include Chipone Technology, Baillie Gifford, Huatai Medical, Light Media, and Haisco Pharmaceutical, which all showed significant price increases on the trading day following the announcement [1][2] - Chipone Technology reported projected revenues of 2.322 billion yuan and a net profit of 601 million yuan for 2024, focusing on AI application solutions [2] - Light Media, a leading player in the entertainment sector, aims to diversify its revenue by becoming an "IP creator and operator" following the success of its animated film "Nezha 2" [2] - Baillie Gifford, specializing in biopharmaceuticals, expects revenues of 5.823 billion yuan in 2024, marking a 936.31% increase year-on-year, with a net profit of 3.708 billion yuan [2] - Haisco Pharmaceutical has 14 commercialized products and new drugs in clinical trials, focusing on innovative drug development [3] - Huatai Medical is recognized as a leading company in domestic electrophysiology and vascular intervention, with new products approved for atrial fibrillation treatment [3] Group 2 - The adjustments made by MSCI will take effect after the market closes on May 30, indicating that stocks entering the MSCI China Index will also be included in the MSCI Global Standard Index series, attracting passive investment tracking [3]